Bridgebio Pharma Inc. (bbio 2.5 03/15/27)
13F holders, Q2 2026 (June 30)6holders −1
1new positions
2sold out
$1.78avg. 13F price*
At the end of Q2 2026, 6 institutions reported holding Bridgebio Pharma Inc. (bbio 2.5 03/15/27) in their 13F filings, down 1 from Q1 2026. 1 opened new positions and 2 sold out. The largest holders were Picton Mahoney Asset Management ($8.9M), State of Wisconsin Investment Board ($7.1M) and Boussard & Gavaudan Gestion Sas ($51K).
- Company
- Bridgebio Pharma Inc. (bbio 2.5 03/15/27)
- CUSIP
- 10806XAB8
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $8.9M |
| Exits | 2 | $2.8M |
All 13F filers, Q1 2026 → Q2 2026: 6,000,000 shares bought and 426,145 shares sold, net +5,573,855 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Picton Mahoney Asset Management | 0.08% | New | 5,000,000 | $8.9M |
| State of Wisconsin Investment Board | 0.01% | Add +33.3% | 4,000,000 | $7.1M |
| Boussard & Gavaudan Gestion Sas | 0.01% | — | 29,000 | $51K |
| Traub Capital Management LLC | 0.02% | No change | 10,000 | $18K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 1,000 | $2K |
| Jones Financial Companies LLLP | 0.00% | No change | 1,000 | $2K |
"% of holder's portfolio" is BRIDGEBIO PHARMA INC (BBIO 2.5 03/15/27)'s weight in each manager's 13F, not the share of Bridgebio Pharma Inc. (bbio 2.5 03/15/27) the manager owns.